Search
for
Sort by
Research 271–300 of 779
- <div>Six years of the IP Indian Journal of Clinical and Experimental Dermatology (2019-2025):&nbsp;<span style="font-size: 1rem;">A bibliometric and thematic analysis</span></div>
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Hair growth–promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- A new era for alopecia areata: New treatments and improved knowledge of the condition
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- 705 Particulate matter induces inflammatory response in human outer root sheath cells via oxidative stress-dependent MAPK and JAK-STAT signaling pathways
- Treatment of Lichen Planopilaris With Abrocitinib
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- 870 Y27632 promotes proliferation via EGFR signaling in a newly isolated and characterized human primary sebocyte cell line
- Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Alopecia Areata: Current Treatments and New Directions
- Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- Clinical and Genetic Aspects of Alopecia Areata: A Cutting Edge Review
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Periplaneta americana extract (L.) promotes hair regrowth in Alopecia areata mice by reducing inflammation and modulating skin microbiota